| Recruiting | A Study to Evaluate the Effect of Itraconazole and Rifampin on the Drug Levels of AR-LDD (BMS-986365) in Healt Healthy Volunteers | Phase 1 | 2025-12-15 |
| Recruiting | A Study to Determine the Recommended Dose and Schedule, and Evaluate the Safety and Preliminary Efficacy of Me Multiple Myeloma | Phase 1 / Phase 2 | 2025-10-07 |
| Recruiting | A Study to Compare the Efficacy and Safety of Golcadomide in Combination With Rituximab (Golca + R) vs Investi Follicular Lymphoma | Phase 3 | 2025-07-28 |
| Recruiting | Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Part Agitation, Alzheimer Disease | Phase 2 | 2025-06-09 |
| Recruiting | A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosi Multiple Sclerosis Spasticity | Phase 2 | 2025-06-05 |
| Recruiting | Study to Evaluate the Effectiveness and Safety of Ozanimod Compared to Fingolimod in Children and Adolescents Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2025-04-08 |
| Recruiting | A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Partic Metastatic Castration-resistant Prostate Cancer | Phase 3 | 2025-03-13 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Lymphoma, Follicular | Phase 2 | 2024-08-30 |
| Completed | Study to Assess Drug Levels and Safety of Golcadomide (BMS-986369) in Healthy Participants and Participants Wi Hepatic Impairment, Healthy Volunteers | Phase 1 | 2024-08-15 |
| Active Not Recruiting | Study to Compare the Effectiveness and Safety of Golcadomide Plus R-CHOP vs Placebo Plus R-CHOP in Participant Large B-cell Lymphoma | Phase 3 | 2024-06-19 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Drug Levels of Orally Administered BMS-986368 in Healthy Par Healthy Participants | Phase 1 | 2024-05-31 |
| Completed | A Study to Evaluate the Drug Levels, Metabolism and Excretion, and Absolute Bioavailability of BMS-986365 in H Healthy Volunteers | Phase 1 | 2024-05-30 |
| Completed | Study to Evaluate Safety, Drug Levels, Food and Relative Bioavailability of BMS-986365 in Healthy Adult Male P Healthy Participants | Phase 1 | 2024-05-28 |
| Withdrawn | A Study to Evaluate Efficacy and Safety of Alnuctamab Compared to Standard of Care Regimens in Participants Wi Multiple Myeloma | Phase 3 | 2024-05-03 |
| Completed | A Study to Evaluate the Effect of Cytochrome P450 (CYP) 3A Inhibitor (Itraconazole) and Inducer (Rifampin) on Healthy Volunteers | Phase 1 | 2024-04-23 |
| Completed | A Study to Evaluate the Drug Levels of Mezigdomide in Adult Participants With Renal Impairment Renal Impairment | Phase 1 | 2024-03-21 |
| Completed | A Study to Assess the Effects of Itraconazole, Food, and pH on the Drug Levels of BMS-986368 in Healthy Partic Healthy Participants | Phase 1 | 2024-03-18 |
| Active Not Recruiting | A Study to Evaluate Alnuctamab in Combination With Mezigdomide in Participants With Relapsed and/or Refractory Multiple Myeloma | Phase 1 | 2024-02-27 |
| Completed | A Study to Evaluate the Absorption, Metabolism, and Excretion of Orally Administered [14C]-BMS-986368 in Healt Healthy Volunteers | Phase 1 | 2024-02-02 |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of Idecabtagene Vicleucel With Lenalidomide Maintenance Therapy Ver Multiple Myeloma | Phase 3 | 2023-10-16 |
| Recruiting | A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dex Relapsed or Refractory Multiple Myeloma | Phase 3 | 2022-09-20 |
| Completed | Safety Study of CC-93538 in Adult and Adolescent Participants With Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 3 | 2022-08-09 |
| Active Not Recruiting | Open-label Study Comparing Iberdomide, Daratumumab and Dexamethasone (IberDd) Versus Daratumumab, Bortezomib, Multiple Myeloma | Phase 3 | 2022-06-23 |
| Completed | A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinoph Eosinophilic Esophagitis | Phase 1 | 2022-06-07 |
| Completed | A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Japanese Participants With Eos Eosinophilic Gastroenteritis | Phase 3 | 2022-03-04 |
| Terminated | A Dose Finding Study of CC-96673 in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin | Phase 1 | 2022-01-20 |
| Terminated | Study to Evaluate Safety and Tolerability of CC-91633 (BMS-986397) in Participants With Relapsed or Refractory Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | 2021-12-02 |
| Completed | A Study to Assess Safety and Tolerability of CC-486 (ONUREG®, Oral Azacitidine) in Combination Therapy in Part Leukemia, Myeloid, Acute | Phase 1 | 2021-12-01 |
| Completed | Safety Study to Evaluate Immune Response of Vaccines in Participants With Relapsing Forms of Multiple Sclerosi Multiple Sclerosis, Multiple Sclerosis, Relapsing-Remitting | Phase 3 | 2021-11-11 |
| Terminated | Connect® Lymphoma Disease Registry: A US-Based Prospective Observational Cohort Study Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular | — | 2021-11-03 |
| Terminated | A Safety, Tolerability and Preliminary Efficacy Study of CC-90011 in Combination With Venetoclax and Azacitidi Leukemia, Myeloid | Phase 1 | 2021-10-14 |
| Withdrawn | Study to Evaluate Tolerability of Iberdomide (CC-220) in Combination With Polatuzumab Vedotin Plus Rituximab o Lymphoma, B-Cell | Phase 1 / Phase 2 | 2021-10-10 |
| Terminated | Study to Evaluate the Safety and Tolerability of CC-92328 in Participants With Relapsed and/or Refractory Mult Multiple Myeloma | Phase 1 | 2021-10-05 |
| Completed | Positron Emission Tomography (PET) Imaging Study to Evaluate Enzyme Availability in the Central Nervous System Healthy Volunteers | Phase 1 | 2021-09-24 |
| Recruiting | Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R-CHOP to Treat Lymphoma Lymphoma, B-Cell | Phase 1 | 2021-09-15 |
| Terminated | A Study of CC-99677 in Participants With Active Ankylosing Spondylitis Spondylitis, Ankylosing | Phase 2 | 2021-08-25 |
| Completed | Study to Evaluate Safety and Tolerability of Iberdomide (CC-220) in Participants With Kidney Impairment Compar Renal Insufficiency | Phase 1 | 2021-08-12 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-99677 in Healthy Adult Healthy Volunteers | Phase 1 | 2021-08-03 |
| Completed | A Study of CC-90011 and Comparators in Participants With Prostate Cancer Prostatic Neoplasms | Phase 1 | 2021-07-28 |
| Completed | Study to Evaluate Additional Risk Minimisation Measures (aRMMs) for REBLOZYL Among Healthcare Professionals (H Myelodysplastic Syndromes, Beta-thalassemia | — | 2021-07-26 |
| Completed | Study to Evaluate the Pressor Effect of Oral Tyramine During Ozanimod Treatment in Healthy Adult Participants Healthy Volunteers | Phase 1 | 2021-07-19 |
| Terminated | Study of CC-96191 in Participants With Relapsed or Refractory Acute Myeloid Leukemia Leukemia, Myeloid | Phase 1 | 2021-06-16 |
| Terminated | Safety and Efficacy of bb2121 (Ide-cel) Combinations in Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2021-06-01 |
| Completed | A Study to Evaluate Safety and Effectiveness of Cendakimab (CC-93538) in Participants With Moderate to Severe Dermatitis, Atopic, Eczema | Phase 2 | 2021-05-14 |
| Active Not Recruiting | An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Subjects With Myeloproliferative Neop Myeloproliferative Disorders, Myelofibrosis, Primary Myelofibrosis | Phase 3 | 2021-02-25 |
| Completed | A Study to Evaluate the Efficacy and Safety of CC-93538 in Adult and Adolescent Participants With Eosinophilic Eosinophilic Esophagitis | Phase 3 | 2021-02-22 |
| Terminated | A Study to Evaluate the My Hematology Oncology Patient Experience (MyHOPE™) For Multiple Myeloma (MM) Digital Multiple Myeloma | Phase 1 | 2021-02-04 |
| Completed | A Study to Assess Safety, Tolerability, and Pharmacokinetics of CC-92480 Formulations in Healthy Adult Partici Healthy Volunteers | Phase 1 | 2021-01-19 |
| Completed | A Study to Evaluate the Effect of a Dual CYP2C19 and CYP3A4 Inhibitor, Fluconazole, on the Pharmacokinetics of Healthy Volunteers | Phase 1 | 2021-01-12 |
| Completed | A Safety and Preliminary Efficacy Study of CC-99282 in Combination With Obinutuzumab in Subjects With Relapsed Lymphoma, Non-Hodgkin | Phase 1 | 2020-12-21 |
| Completed | A Phase 1, Multicenter, Open-Label Study to Evaluate the Effect of Mild or Moderate Hepatic Impairment on the Liver Diseases, Digestive System Diseases | Phase 1 | 2020-12-18 |
| Completed | Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL) Lymphoma Nonhodgkin | — | 2020-12-17 |
| Completed | Metabolism and Excretion of [14C]CC-90001 in Healthy Male Subjects Healthy Volunteer | Phase 1 | 2020-12-16 |
| Unknown | A Study to Evaluate the Efficacy, Drug Levels and Safety of Luspatercept (ACE-536) for the Treatment of Anemia Myelodysplastic Syndromes | Phase 2 | 2020-11-30 |
| Completed | Pharmacokinetics of Enasidenib (CC-90007) in Participants With Mild, Moderate and Severe Hepatic Impairment Hepatic Impairment | Phase 1 | 2020-11-13 |
| Terminated | A Dose Finding and Safety Study of CC-220, Alone and in Combination With an Anti-CD20 Monoclonal Antibody (mAb Lymphoma | Phase 1 | 2020-11-11 |
| Completed | A Study to Evaluate the Metabolism and Excretion of [14C]-CC-92480 in Healthy Male Participants Healthy Volunteers | Phase 1 | 2020-10-15 |
| Completed | A Study to Evaluate the Relative Bioavailability of a Pediatric Granule Formulation of Ozanimod in Healthy Adu Healthy Volunteers | Phase 1 | 2020-10-07 |
| Completed | A Study to Evaluate Effects of CC-99677 on the Pharmacokinetics of an Oral Contraceptive in Healthy Female Par Healthy Volunteers | Phase 1 | 2020-09-30 |
| Completed | A Study to Evaluate the Pharmacokinetics of Single Oral Doses of Ozanimod in Healthy Adult Chinese Subjects Healthy Volunteer | Phase 1 | 2020-08-12 |
| Terminated | A Safety and Efficacy Study of CC-90009 Combinations in Subjects With Acute Myeloid Leukemia Leukemia, Myeloid, Acute | Phase 1 | 2020-08-05 |
| Completed | A Safety and Efficacy Study of CC-90011 in Combination With Nivolumab in Subjects With Advanced Cancers Neoplasms | Phase 2 | 2020-07-14 |
| Active Not Recruiting | A Study to Evaluate the Efficacy and Safety of JCAR017 in Adult Subjects With Relapsed or Refractory Indolent Lymphoma, Non-Hodgkin | Phase 2 | 2020-07-14 |
| Terminated | A Study of CC-90010 in Combination With Temozolomide With or Without Radiation Therapy in Participants With Ne Glioblastoma | Phase 1 | 2020-07-10 |
| Completed | Study to Evaluate the Safety and Tolerability of CC-94676 in Participants With Metastatic Castration-Resistant Prostatic Neoplasms | Phase 1 | 2020-06-22 |
| Completed | Study to Evaluate the Pharmacokinetic Comparability of CC-93538 From Two Different Drug Concentrations in Heal Healthy Volunteers | Phase 1 | 2020-06-22 |
| Completed | A Study to Evaluate the Safety of bb2121 in Subjects With High Risk, Newly Diagnosed Multiple Myeloma (NDMM) Multiple Myeloma | Phase 1 | 2020-05-27 |
| Completed | A Study to Evaluate Potential Cytochrome P450 and Transporter Protein Interactions With CC-99677 Healthy Volunteer | Phase 1 | 2020-03-13 |
| Terminated | Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of CC-97489 in Healthy Adult Healthy Volunteers | Phase 1 | 2020-03-13 |
| Completed | A Study to Evaluate the Metabolism and Excretion of [14C]-CC-90009 in Healthy Male Subjects Healthy Volunteer | Phase 1 | 2020-03-11 |
| Terminated | Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozan Multiple Sclerosis | Phase 3 | 2020-01-16 |
| Terminated | CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic A Astrocytoma, Glioblastoma | Phase 1 | 2020-01-02 |
| Completed | Influence of Fedratinib on the Pharmacokinetics of the Transporter Probe Substrates Digoxin, Rosuvastatin, and Healthy Volunteers | Phase 1 | 2019-12-18 |
| Completed | A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysp Myelodysplastic Syndromes, Lymphoma, Mantle-Cell, Lymphoma, Follicular | — | 2019-11-28 |
| Recruiting | Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia Beta-Thalassemia | Phase 2 | 2019-11-07 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetic and Pharmacodynamic of CC-95775 in Subjects With A Lymphoma, Non-Hodgkin | Phase 1 | 2019-10-24 |
| Completed | Relative Bioavailability and PPI Effects of CC-92480 Test and Reference Formulations in Healthy Subjects Healthy Volunteer | Phase 1 | 2019-10-21 |
| Completed | Japanese Pharmacokinetic Bridging Study for CC-93538 Healthy Volunteers | Phase 1 | 2019-10-14 |
| Completed | Bioavailability of Enasidenib (CC-90007) Sprinkle Formulation Relative to the Reference Tablet Formulation and Healthy Volunteers | Phase 1 | 2019-10-09 |
| Completed | Drug Interaction Study of the Effect on Cyclosporine on Ozanimod and Major Active Metabolites Healthy Volunteers | Phase 1 | 2019-10-04 |
| Active Not Recruiting | A Study to Determine the Recommended Dose and Regimen and to Evaluate the Safety and Preliminary Efficacy of C Multiple Myeloma | Phase 1 / Phase 2 | 2019-09-30 |
| Completed | An Efficacy and Safety Study of Fedratinib Compared to Best Available Therapy in Subjects With DIPSS-intermedi Primary Myelofibrosis, Post-Polycythemia Vera, Myelofibrosis | Phase 3 | 2019-09-09 |
| Completed | A Pharmacokinetics and Tolerability Study of Fedratinib in Subjects With Moderate and Severe Hepatic Impairmen Healthy Volunteers, Hepatic Impairment | Phase 1 | 2019-09-04 |
| Completed | Pharmacogenetics Sampling of the CC-90007-CP-003 Study Cohort Hepatic Insufficiency | — | 2019-09-04 |
| Terminated | A Study of CC-99712, a BCMA Antibody-Drug Conjugate, in Participants With Relapsed and Refractory Multiple Mye Multiple Myeloma | Phase 1 | 2019-08-26 |
| Terminated | Study to Evaluate the Efficacy and Safety of CC-90001 in Participants With Non-alcoholic Steatohepatitis (NASH Non-alcoholic Fatty Liver Disease, Liver Cirrhosis | Phase 2 | 2019-08-14 |
| Recruiting | A Study to Evaluate Long-term Safety in Participants Who Have Participated in Other Luspatercept (ACE-536) Cli Myelodysplastic Syndromes (MDS), Beta-thalassemia, Myeloproliferative Neoplasm(MPN)-Associated Myelofibrosis | Phase 3 | 2019-08-12 |
| Terminated | A Study to Evaluate Immune Biomarker Modulation in Response to VTX-2337 in Combination With an Anti- PD-1 Inhi Carcinoma, Squamous Cell | Phase 1 | 2019-07-03 |
| Completed | Effect of Rifampin and Efavirenz on the Pharmacokinetics of Fedratinib in Healthy Adult Subjects Healthy Volunteers | Phase 1 | 2019-06-21 |
| Completed | To Evaluate Efficacy and Long-term Safety of Ozanimod in Japanese Subjects With Moderately to Severely Active Colitis, Ulcerative | Phase 3 | 2019-06-03 |
| Terminated | A Study of Tislelizumab (BGB-A317) Plus Chemoradiotherapy Followed by Tislelizumab Monotherapy in Newly Diagno Carcinoma, Non-Small-Cell Lung | Phase 3 | 2019-05-22 |
| Active Not Recruiting | A Safety and Preliminary Efficacy Study of CC-99282, Alone and in Combination With Anti-lymphoma Agents in Par Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | 2019-05-20 |
| Completed | An Efficacy and Safety Study of Luspatercept (ACE-536) for the Treatment of Anemia Due to IPSS-R Very Low, Low Myelodysplastic Syndromes | Phase 2 | 2019-05-20 |
| Active Not Recruiting | Efficacy and Safety Study of bb2121 Versus Standard Regimens in Subjects With Relapsed and Refractory Multiple Multiple Myeloma | Phase 3 | 2019-04-16 |
| Completed | A Study of Safety, Tolerability, and Pharmacokinetics of Multiple-Dose CC-90001 in Japanese and Caucasian Heal Healthy Volunteer | Phase 1 | 2019-04-04 |
| Terminated | A Trial of Fedratinib in Subjects With DIPSS, Intermediate or High-Risk Primary Myelofibrosis, Post-Polycythem Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, Myelofibrosis | Phase 3 | 2019-03-27 |
| Completed | A Study to Evaluate the Relationship of Lenalidomide With Tumor Flare Reaction and High Tumor Burden in Partic Lymphoma, Mantle-Cell | — | 2019-03-13 |
| Completed | A Safety, Tolerability and Preliminary Efficacy Evaluation of CC-90011 Given in Combination With Cisplatin and Small Cell Lung Carcinoma | Phase 1 | 2019-03-12 |
| Terminated | A Study of CC-95251, a Monoclonal Antibody Directed Against SIRPα, in Participants With Advanced Solid and Hem Neoplasms | Phase 1 | 2019-03-01 |
| Completed | Evaluate the Pharmacokinetics of CC-220 in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared Hepatic Impairment, Healthy Volunteers | Phase 1 | 2019-02-13 |
| Completed | ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma Lymphoma, T-Cell, Peripheral | — | 2019-02-04 |
| Active Not Recruiting | A Study to Compare the Efficacy and Safety of Luspatercept (ACE-536) Versus Epoetin Alfa for the Treatment of Myelodysplastic Syndromes | Phase 3 | 2019-01-02 |
| Completed | Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Food Effect of Single Ascending Doses of CC-9248 Healthy Volunteer | Phase 1 | 2018-12-21 |
| Completed | An Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma and in Subjec Multiple Myeloma | Phase 2 | 2018-12-13 |
| Completed | A Study to Assess the Pharmacokinetics of CC-90001 in Subjects With Mild, Moderate, and Severe Hepatic Impairm Hepatic Impairment | Phase 1 | 2018-12-06 |
| Active Not Recruiting | Efficacy and Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patients With Re Lymphoma, T-Cell | Phase 3 | 2018-11-06 |
| Completed | A Study to Compare the Efficacy and Safety of JCAR017 to Standard of Care in Adult Subjects With High-risk, Tr Lymphoma, Non-Hodgkin | Phase 3 | 2018-10-23 |
| Terminated | A Study to Evaluate the Safety and Efficacy of JCAR017 in Pediatric Subjects With Relapsed/Refractory (r/r) B- Precursor Cell Lymphoblastic Leukemia-Lymphoma, Lymphoma, Non-Hodgkin | Phase 1 / Phase 2 | 2018-10-17 |
| Completed | A Study of Perpetrator Drug Interactions of Enasidenib in AML Patients Leukemia, Myeloid, Acute | Phase 1 | 2018-10-04 |
| Completed | Extension Study to Further Evaluate the Safety, Pharmacodynamics and Pharmacokinetics of Ozanimod and Active M Healthy Volunteers | — | 2018-09-10 |
| Terminated | An Extension Study of Oral Ozanimod for Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 3 | 2018-08-24 |
| Terminated | A Safety Study of CC-92252 in Healthy Adult Subjects and Adult Subjects With Psoriasis Healthy Volunteers, Psoriasis | Phase 1 | 2018-07-24 |
| Completed | Drug-drug Interaction Study of Ozanimod With Tyramine to Evaluate the Effect on Pressor Response Healthy Volunteer | Phase 1 | 2018-07-24 |
| Completed | A Study of the First-line Treatment of Patients With Newly Diagnosed Transplant-ineligible Multiple Myeloma in Multiple Myeloma | — | 2018-07-19 |
| Recruiting | Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells Neoplasms | Phase 2 / Phase 3 | 2018-07-19 |
| Completed | Drug-drug Interaction Study of Ozanimod With Pseudoephedrine to Evaluate the Effect on Blood Pressure and Hear Healthy Volunteers | Phase 1 | 2018-07-11 |
| Terminated | A Placebo-Controlled Study of Oral Ozanimod as Maintenance Therapy for Moderately to Severely Active Crohn's D Crohn Disease | Phase 3 | 2018-06-27 |
| Completed | Drug-drug Interaction Study of Ozanimod With Inhibitor or Inducer of CYP2C8 and/or CYP3A Healthy Volunteer | Phase 1 | 2018-06-20 |
| Completed | Trial to Determine the Efficacy and Safety of JCAR017 in Adult Participants With Aggressive B-Cell Non-Hodgkin Lymphoma, Non-Hodgkin | Phase 2 | 2018-06-05 |
| Completed | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Do Healthy Volunteer | Phase 1 | 2018-05-23 |
| Completed | A Study to Evaluate Gluten Challenge on Immune Responses in Subjects With Celiac Disease Celiac Disease | — | 2018-05-11 |
| Terminated | Study of CC-93269, a BCMA x CD3 T Cell Engaging Antibody, in Participants With Relapsed and Refractory Multipl Multiple Myeloma | Phase 1 | 2018-04-03 |
| Completed | Induction Study #2 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 3 | 2018-03-07 |
| Completed | Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain Leukemia, Myeloid, Acute | — | 2018-02-28 |
| Terminated | Induction Study #1 of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease Crohn Disease | Phase 3 | 2018-02-27 |
| Terminated | A Safety, PK and Efficacy Study of CC-92480 Monotherapy and in Combination With Dexamethasone in Subjects With Multiple Myeloma | Phase 1 / Phase 2 | 2018-02-06 |
| Completed | A Study to Determine the Efficacy and Safety of Luspatercept in Adults With Non Transfusion Dependent Beta (β) Thalassemia | Phase 2 | 2018-02-05 |
| Completed | Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 Psoriasis | Phase 1 | 2018-01-04 |
| Completed | Post Marketing Surveillance on Safety Evaluation of POMALYST® (Pomalidomide) Treatment of Multiple Myeloma in Multiple Myeloma | — | 2017-12-28 |
| Completed | A Safety and Efficacy Trial of JCAR017 Combinations in Subjects With Relapsed/Refractory B-cell Malignancies Lymphoma, Non-Hodgkin, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular | Phase 1 / Phase 2 | 2017-12-20 |
| Completed | Efficacy and Safety Study of bb2121 in Subjects With Relapsed and Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2017-12-13 |
| Completed | A Study to Estimate the Effect Sizes of HRCT Endpoints in Response to Glucocorticoid Induction Therapy in Subj Sarcoidosis, Pulmonary | N/A | 2017-12-08 |
| Completed | A Study to Evaluate the Effect of Multiple Doses of CC-90001 on the Pharmacokinetics of Omeprazole, Midazolam, Heathy Volunteer | Phase 1 | 2017-12-04 |
| Withdrawn | A Study of Efficacy and Safety of Mongersen (GED-0301) for the Treatment of Adult and Adolescent Subjects With Crohn Disease | Phase 3 | 2017-12-01 |
| Completed | A Safety and Efficacy Study to Evaluate Luspatercept in Subjects With Myeloproliferative Neoplasm-associated M Primary Myelofibrosis, Anemia | Phase 2 | 2017-11-15 |
| Completed | Study Evaluating the Effects of Food, Cytochrome P450 Inhibition and Induction on the Pharmacokinetics of CC-1 Healthy Volunteer | Phase 1 | 2017-11-09 |
| Completed | Study of Safety and Efficacy of Avadomide (CC-122) Combined With RCHOP for Newly-diagnosed DLBCL With Poor Ris Diffuse B-Cell Lymphoma | Phase 1 | 2017-10-04 |
| Completed | A Study to Assess the Pharmacokinetics of Enasidenib (CC-90007) in Subjects With Moderate and Severe Hepatic I Hepatic Impairment | Phase 1 | 2017-09-21 |
| Completed | A Study of Pomalidomide Monotherapy for Children and Young Adults With Recurrent or Progressive Primary Brain Central Nervous System Neoplasms, Medulloblastoma | Phase 2 | 2017-09-18 |
| Completed | Radiolabeled Study of CC-220 in Healthy Male Subjects Healthy Volunteer | Phase 1 | 2017-09-11 |
| Completed | A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus Lupus Erythematosus, Systemic | Phase 2 | 2017-08-31 |
| Terminated | A Study to Evaluate the Efficacy and Safety of CC-90001 in Subjects With Idiopathic Pulmonary Fibrosis Idiopathic Pulmonary Fibrosis, Fibrosis, Idiopathic Interstitial Pneumonias | Phase 2 | 2017-07-26 |
| Terminated | A Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of CC-90010 in Subjects Lymphoma, Non-Hodgkin, Neoplasms | Phase 1 | 2017-07-24 |
| Completed | Use Lenalidomide (Revlimid®) in Combination With Dexamethasone in Clinical Practice for the Treatment of Newly Multiple Myeloma | — | 2017-06-30 |
| Completed | Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL) Lymphoma | — | 2017-05-30 |
| Completed | A Study to Assess the Relative Bioavailability of a New CC-220 Capsule Formulation, Compared to a Reference CC Healthy Volunteers | Phase 1 | 2017-05-24 |
| Active Not Recruiting | A Safety Study of Lenalidomide in Previously Untreated Adult Multiple Myeloma Patients Who Are Not Eligible fo Multiple Myeloma | — | 2017-03-31 |
| Completed | A Study to Assess the Pharmacokinetics of CC-122 in Subjects With Mild, Moderate, and Severe Renal Impairment Renal Insufficiency | Phase 1 | 2017-03-30 |
| Completed | A Study to Determine the Efficacy of the Combination of Daratumumab (DARA) Plus Durvalumab (DURVA) (D2) in Sub Multiple Myeloma | Phase 2 | 2017-03-14 |
| Completed | A Study of Durvalumab in Combination With R-CHOP or Lenalidomide Plus R-CHOP in Previously Untreated High-Risk Lymphoma, Large B-Cell, Diffuse | Phase 2 | 2017-02-28 |
| Completed | A Study to Assess Disease Burden, in Terms of Health-related Quality of Life and Direct Healthcare Costs, in P Multiple Myeloma | — | 2016-12-25 |
| Withdrawn | A Study to Determine Safety, Feasibility and Efficacy of JCAR015 in Adult Subjects With B-Cell Acute Lymphobla Precursor Cell Lymphoblastic Leukemia-Lymphoma | Phase 1 / Phase 2 | 2016-12-20 |
| Completed | A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 in Healthy Subjects Healthy Volunteers | Phase 1 | 2016-11-21 |
| Terminated | A Dose-finding Study of CC-90009 in Subjects With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | 2016-11-14 |
| Completed | A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmaco Healthy Volunteers | Phase 1 | 2016-11-01 |
| Active Not Recruiting | A Study to Determine Dose, Safety, Tolerability and Efficacy of CC-220 Monotherapy, and in Combination With Ot Multiple Myeloma | Phase 1 / Phase 2 | 2016-10-14 |
| Completed | A Single Dose Oral Excretion Balance Study of [14C]-RPC1063 in Healthy Male Adults Healthy Volunteers | Phase 1 | 2016-10-01 |
| Completed | Selective HDAC6 Inhibitor ACY-241 in Combination With Ipilimumab and Nivolumab Malignant Melanoma | Phase 1 | 2016-09-30 |
| Completed | A Safety and Efficacy Study of CC-122 in Combination With Nivolumab in Subjects With Unresectable Hepatocellul Carcinoma, Hepatocellular | Phase 1 / Phase 2 | 2016-09-20 |
| Terminated | A Safety and Efficacy Study of CC-90011 in Participants With Relapsed and/or Refractory Solid Tumors and Non-H Lymphoma, Non-Hodgkin, Neoplasms | Phase 1 | 2016-08-31 |
| Terminated | Selective HDAC6 Inhibitor ACY 241 in Combination With Nivolumab in Patients With Unresectable Non Small Cell L Non Small Cell Lung Cancer | Phase 1 | 2016-08-25 |
| Completed | Study of Marizomib With Temozolomide and Radiotherapy in Patients With Newly Diagnosed Brain Cancer Glioblastoma, Malignant Glioma | Phase 1 | 2016-08-17 |
| Terminated | A Long-term Active Treatment Study of Mongersen (GED-0301) in Subjects With Crohn's Disease Crohn's Disease | Phase 3 | 2016-07-25 |
| Completed | A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance Myelodysplastic Syndromes, Leukemia Myeloid Acute, Multiple Myeloma | — | 2016-07-20 |
| Terminated | A Study to Determine the Safety and Efficacy for the Combination of Durvalumab and Daratumumab in Relapsed and Multiple Myeloma | Phase 2 | 2016-07-07 |
| Completed | Pharmacokinetics and Pharmacodynamics Study of RPC1063 in RMS Multiple Sclerosis | Phase 1 | 2016-06-23 |
| Completed | An Efficacy and Safety Study of Azacitidine Subcutaneous in Combination With Durvalumab (MEDI4736) in Previous Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 2 | 2016-06-03 |
| Active Not Recruiting | A Study to Assess the Safety and Efficacy of Two Combinations of Isocitrate Dehydrogenase (IDH) Mutant Targete Leukemia, Myeloid, Acute | Phase 1 / Phase 2 | 2016-06-03 |
| Completed | A Study to Determine Dose, Safety, and Efficacy of Durvalumab as Monotherapy and in Combination Therapy in Sub Lymphoma, Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | 2016-05-11 |
| Completed | An Efficacy and Safety Study of Luspatercept (ACE-536) Versus Placebo in Adults Who Require Regular Red Blood Erythrocyte Transfusion, Beta-Thalassemia | Phase 3 | 2016-05-02 |
| Completed | Longterm Follow-up of Subjects Treated With bb2121 Multiple Myeloma | — | 2016-04-28 |
| Completed | A Study of Durvalumab in Combination With Lenalidomide With and Without Dexamethasone in Adults With Newly Dia Multiple Myeloma | Phase 1 / Phase 2 | 2016-04-25 |
| Terminated | Pharmacodynamic and Clinical Outcome Study of Mongersen in Patients With Crohn's Disease Crohn's Disease | Phase 2 | 2016-04-04 |
| Completed | Revlimid® Capsules Special Drug Use-results Survey (in Patients With Newly-diagnosed Multiple Myeloma [NDMM]) Multiple Myeloma | — | 2016-03-03 |
| Terminated | A Study of CC-90002 in Subjects With Acute Myeloid Leukemia (AML) and High-risk Myelodysplastic Syndrome (MDS) Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 | 2016-03-01 |
| Completed | To Document the Burden of Illness on the Quality of Life and the Impact on Healthcare Utilization in (Beta) β- Beta-Thalassemia | — | 2016-03-01 |
| Completed | Safety Study of Lenalidomide/Dexamethasone to Treat Patients With Relapsed or Refractory Multiple Myeloma Multiple Myeloma | — | 2016-02-25 |
| Completed | A Study of Luspatercept (ACE-536) to Treat Anemia Due to Very Low, Low, or Intermediate Risk Myelodysplastic S Myelodysplastic Syndromes | Phase 3 | 2016-02-09 |
| Completed | Study of 5-fluorouracil (5-FU), Nab®1-paclitaxel, Bevacizumab, Leucovorin, and Oxaliplatin in Patients With Me Metastatic Pancreas Adenocarcinoma | Phase 1 | 2016-01-18 |
| Completed | A Study to Determine Dose and Regimen of Durvalumab as Monotherapy or in Combination With Pomalidomide With or Multiple Myeloma | Phase 1 | 2016-01-11 |
| Completed | An Efficacy and Safety Study of AG-221 (CC-90007) Versus Conventional Care Regimens in Older Subjects With Lat Leukemia, Myeloid, Isocitrate Dehydrogenase | Phase 3 | 2015-12-30 |
| Completed | ACY 241 in Combination With Paclitaxel in Patients With Advanced Solid Tumors Advanced Solid Tumors | Phase 1 | 2015-12-22 |
| Completed | Study of bb2121 in Multiple Myeloma Multiple Myeloma | Phase 1 | 2015-12-22 |
| Completed | An Efficacy and Safety Study of Mongersen (GED-0301) in Subjects With Active Ulcerative Colitis Colitis, Ulcerative | Phase 2 | 2015-12-14 |
| Terminated | Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease Crohn Disease | Phase 3 | 2015-12-08 |
| Completed | An Extension Study of RPC1063 as Therapy for Moderate to Severe Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2015-12-02 |
| Completed | A Study of Lenalidomide in Pediatric Subjects With Relapsed or Refractory Acute Myeloid Leukemia Leukemia, Myeloid | Phase 2 | 2015-11-19 |
| Completed | A Study to Evaluate Long-term Safety of CC-486 (Oral Azacitidine) in Subjects With Hematological Disorders Hematologic Neoplasm, Neoplasms, Hematologic Malignancies | Phase 2 | 2015-10-22 |
| Completed | A Multi-Site, Open-Label Extension Trial of Oral RPC1063 in Relapsing Multiple Sclerosis Multiple Sclerosis | Phase 3 | 2015-10-16 |
| Completed | Efficacy and Safety Trial of RPC1063 for Moderate to Severe Crohn's Disease Crohn's Disease | Phase 2 | 2015-10-09 |
| Completed | Safety and Efficacy Study of CC-486 With MK-3475 to Treat Locally Advanced or Metastatic Non-small Cell Lung C Carcinoma, Non-Small-Cell Lung | Phase 2 | 2015-10-09 |
| Terminated | A Study to Assess Clinical an Patient Reported Outcomes With Nab-paclitaxel in Combination With Gemcitabine in Pancreatic Neoplasms | — | 2015-10-01 |
| Completed | Study With Azacitidine in Pediatric Subjects With Newly Diagnosed Advanced Myelodysplastic Syndrome (MDS) and Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Juvenile | Phase 2 | 2015-09-15 |
| Terminated | A Study of CC-122 to Assess the Safety and Tolerability in Japanese Patients With Advanced Solid Tumors and No Lymphoma, Non-Hodgkin | Phase 1 | 2015-09-02 |
| Completed | Study to Evaluatethe Bioavailability and Food Effect Lenalidomide as an Oral Suspension Healthy Volunteers | Phase 1 | 2015-08-14 |
| Completed | A Study of Safety, Efficacy and Pharmacodynamics of Azacitidine in Children and Young Adults With Acute Myeloi Leukemia, Myeloid, Acute | Phase 2 | 2015-08-12 |
| Completed | Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis Pulmonary Fibrosis | Phase 1 | 2015-08-05 |
| Completed | A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab Leukemia, Lymphocytic, Chronic, B-Cell | Phase 1 / Phase 2 | 2015-07-27 |
| Terminated | Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis Parapsoriasis, Healthy Volunteers | Phase 1 | 2015-07-17 |
| Completed | Safety and Efficacy Study of CC-486 in Subjects With Myelodysplastic Syndromes Myelodysplastic Syndromes | Phase 2 | 2015-07-06 |
| Completed | Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis Ulcerative Colitis | Phase 3 | 2015-06-17 |
| Terminated | Pharmacokinetic and Safety Study of Nab®-Paclitaxel (ABI-007) Plus Gemcitabine in Subjects With Advanced Pancr Pancreatic Neoplasms, Cholestasis | Phase 1 | 2015-05-27 |
| Completed | A Phase 1b Open-label Study to Evaluate the Safety and Efficacy of CC-122 With Obinutuzumab (GA101) in Relapse Lymphoma, Large B-Cell, Diffuse, Lymphoma, Non-Hodgkin | Phase 1 | 2015-05-22 |
| Completed | Radiolabeled Study of AG-221 in Healthy Male Subjects. Healthy Volunteers | Phase 1 | 2015-05-14 |
| Completed | Treatment of Pancreatic Cancer With Abraxane Metastatic Pancreatic Cancer | — | 2015-05-08 |
| Terminated | Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma Multiple Myeloma | Phase 1 | 2015-05-07 |
| Completed | A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst Multiple Myeloma | — | 2015-04-30 |
| Completed | A Phase 1, Open-label Trial of Oral Azacitidine (CC-486) Plus RCHOP in Subjects With Large B-Cell Lymphoma or Lymphoma, Large B-Cell, Diffuse, Lymphoma, Follicular | Phase 1 | 2015-04-29 |
| Completed | Phase II Safety and Tolerability Trial With Nab-Paclitaxel Plus Carboplatin Followed by Nab-Paclitaxel for Fir Carcinoma, Non-Small-Cell Lung | Phase 2 | 2015-04-28 |
| Completed | Phase 2 Nab® -Paclitaxel (Abraxane®) Plus Gemcitabine in Subjects With Locally Advanced Pancreatic Cancer (LAP Pancreatic Neoplasms | Phase 2 | 2015-04-21 |
| Completed | Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib Malignant Glioma, Glioblastoma | Phase 1 / Phase 2 | 2015-04-15 |
| Completed | A Randomized, Double-blind, Study to Explore the Effect of GED-0301 in Subjects With Active Crohn's Disease Crohn Disease | Phase 1 | 2015-04-08 |
| Completed | Observational Study of Lenalidomide in Subjects With Mantle Cell Lymphoma Who Failed Ibrutinib Treatment Lymphoma, Mantle-Cell | — | 2015-04-01 |
| Completed | An Efficacy Study of Pomalidomide in Patient With Multiple Myeloma in Routine Clinical Practice Multiple Myeloma | — | 2015-04-01 |
| Terminated | Study to Assess the Efficacy and Safety of the Epigenetic Modifying Effects of CC-486 (Oral Azacitidine) in Co Breast Neoplasms | Phase 2 | 2015-03-13 |
| Completed | A Phase 1, Dose Finding Study of CC-90002 in Subjects With Advanced Solid and Hematologic Cancers Hematologic Neoplasms | Phase 1 | 2015-03-12 |
| Completed | PK and Safety Study of AG-221 in Healthy Male Japanese Subjects and Healthy Male Caucasian Subjects Healthy | Phase 1 | 2015-03-02 |
| Completed | Treatment of Relapsed/Refractory Multiple Myeloma (rrMM) With Pomalidomide in Clinical Practice Multiple Myeloma | — | 2015-02-20 |
| Completed | Efficacy and Safety Study of Lenalidomide Plus R-CHOP Chemotherapy Versus Placebo Plus R-CHOP Chemotherapy in Lymphoma, Large B-Cell, Diffuse | Phase 3 | 2015-02-17 |
| Completed | Safety and Efficacy of CC-486 in Previously Treated Patients With Locally Advanced or Metastatic Nasopharyngea Nasopharyngeal Neoplasms | Phase 2 | 2015-02-13 |
| Terminated | Safety and Efficacy Study of CC-122 Combined With Sorafenib for Primary Liver Cancer Carcinoma, Hepatocellular | Phase 1 | 2015-01-16 |
| Completed | Safety Study of Nivolumab With Nab-Paclitaxel Plus or Minus Gemcitabine in Pancreatic Cancer, Nab-Paclitaxel / Breast Neoplasms, Pancreatic Neoplasms | Phase 1 | 2015-01-12 |
| Completed | Safety and Efficacy Study of Nab®-Paclitaxel With CC-486 or Nab®-Paclitaxel With Durvalumab, and Nab®-Paclitax Carcinoma, Non-Small-Cell Lung | Phase 2 | 2015-01-07 |
| Terminated | Safety and PK Study of CC-90003 in Relapsed/Refractory Solid Tumors Neoplasm Metastasis | Phase 1 | 2015-01-05 |
| Completed | Non-interventional Study of Lenalidomide in the Clinical Routine Treatment of TD Patients With IPSS Low or Int Myelodysplastic Syndrome | — | 2014-12-17 |
| Completed | Observational Study of Quality of Live in Patients With Metastatic Pancreatic Cancer Pancreatic Neoplasms | — | 2014-12-10 |
| Completed | Study of Orally Administered Enasidenib (AG-221) in Adults With Advanced Solid Tumors, Including Glioma, or An Solid Tumor, Glioma, Angioimmunoblastic T-cell Lymphoma | Phase 1 / Phase 2 | 2014-12-08 |
| Completed | Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis (MS) Multiple Sclerosis | Phase 3 | 2014-12-03 |
| Withdrawn | A Phase 2 Study With CC-220 in Skin Sarcoidosis Sarcoidosis | Phase 2 | 2014-11-01 |
| Terminated | A Phase Ib Study of Neoadjuvant of Cetuximab Plus Motolimod and Cetuximab Plus Motolimod Plus Nivolumab Squamous Cell Carcinoma of the Head and Neck | Phase 1 | 2014-10-28 |
| Completed | Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies Hematological Neoplasms, Non-Hodgkin's Lymphoma, Hodgkin's Lymphoma | Phase 1 | 2014-10-27 |
| Completed | Radiolabeled Study of CC-122 in Healthy Subjects Healthy Volunteers | Phase 1 | 2014-09-23 |
| Completed | A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. Systemic Lupus Erythematosus | Phase 2 | 2014-09-16 |
| Completed | Phase 1b Study Evaluating ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Dexamethasone in Relaps Multiple Myeloma | Phase 1 | 2014-09-15 |
| Completed | Dose Ranging Study of RPC4046 in Eosinophilic Esophagitis Eosinophilic Esophagitis | Phase 2 | 2014-08-31 |
| Withdrawn | Continuous Lenalidomide Therapy Versus Observation Following Induction Without Lenalidomide, Pomalidomide or T Multiple Myeloma, Neoplasms, Plasma Cells | Phase 3 | 2014-07-01 |
| Completed | A Post Authorisation Registry of IMNOVID (Pomalidomide) for Patients With Relapsed and Refractory Multiple Mye Multiple Myeloma | — | 2014-06-26 |
| Completed | Safety and Efficacy Study of Abraxane in Combination With Carboplatin to Treat Advanced NSCL Cancer in the Eld Non-Small Cell Lung Cancer, Carcinoma, Squamous Cell Carcinoma | Phase 4 | 2014-06-09 |
| Completed | Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple M Multiple Myeloma in Relapse, Refractory Multiple Myeloma, Multiple Myeloma | Phase 1 | 2014-06-05 |
| Completed | Food Effect and CYP1A2 Induction Study in Healthy Subjects Healthy Volunteers | Phase 1 | 2014-05-30 |
| Completed | Pomalidomide in Combination With Low-dose Dexamethasone or Pomalidomide in Combination With Low-dose Dexametha Multiple Myeloma | Phase 2 | 2014-05-29 |
| Completed | Relative Bioavailability Study of CC-292 Healthy Volunteers | Phase 1 | 2014-05-26 |
| Completed | Phase 2 Study With Abraxane (Nab®Paclitaxel) in Metastatic Colorectal Cancer Colorectal Neoplasms | Phase 2 | 2014-05-05 |
| Completed | Lenalidomide vs Placebo Maintenance Therapy Following Melphalan Prednisone Velcade® Induction Therapy in NDMM Multiple Myeloma | Phase 3 | 2014-04-30 |
| Completed | Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Foll Lymphoma, Non-Hodgkin | Phase 3 | 2014-04-01 |
| Completed | Nab-paclitaxel and Gemcitabine vs Gemcitabine Alone as Adjuvant Therapy for Patients With Resected Pancreatic Pancreatic Neoplasms, Digestive System Neoplasms, Neoplasms by Site | Phase 3 | 2014-03-28 |
| Completed | Quality of Life in Metastatic Breast Cancer (MBC) Patients in Second Line Monochemotherapy Breast Neoplasms | — | 2014-03-12 |
| Terminated | ACY-1215 (Ricolinostat) in Combination With Pomalidomide and Low-dose Dex in Relapsed-and-Refractory Multiple Multiple Myeloma | Phase 1 / Phase 2 | 2014-03-01 |
| Completed | Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency Multiple Myeloma | Phase 2 | 2014-02-28 |
| Completed | Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Sta Squamous Cell Carcinoma, Non-Small-Cell Lung | Phase 3 | 2014-02-11 |
| Completed | Study to Evaluate Pharmacokinetics of Single Oral Doses of Formulated and Non-Formulated CC-122, and Food Effe Clinical Pharmacology, Healthy Male Volunteer Study | Phase 1 | 2014-01-16 |
| Completed | A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046. Pancreatic Cancer | — | 2014-01-02 |
| Unknown | A Non-interventional,Observational Post Authorization Study of Patients With Multiple Myeloma Treated With Len Multiple Myeloma | — | 2013-12-25 |
| Completed | Safety and Efficacy Study of Nab-paclitaxel Plus Gemcitabine in Chinese Patients With Metastatic Pancreatic Ca Pancreatic Neoplasms | Phase 2 | 2013-12-24 |
| Terminated | Novel Combinations of CC-122, CC-223, CC-292, and Rituximab in Diffuse Large B-cell Lymphoma and Follicular Ly Lymphoma, Large B-Cell, Diffuse | Phase 1 | 2013-12-18 |
| Terminated | Connect® Myeloid Disease Registry Primary Myelofibrosis, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | — | 2013-12-12 |
| Completed | Study to Find a Safe Dose and Show Early Clinical Activity of Weekly Nab-paclitaxel in Pediatric Patients With Neuroblastoma, Rhabdomyosarcoma, Ewing's Sarcoma | Phase 1 / Phase 2 | 2013-12-04 |
| Completed | Efficacy and Safety Study of Ozanimod in Relapsing Multiple Sclerosis Relapsing Multiple Sclerosis | Phase 3 | 2013-12-03 |
| Completed | A Phase 2 Study of Intravenous or Subcutaneous Dosing of Sotatercept (ACE-011) in Patients With End-Stage Kidn Anemia, Kidney Failure, Chronic | Phase 2 | 2013-11-30 |
| Completed | Rituximab Plus Lenalidomide for Patients With Relapsed / Refractory Indolent Non-Hodgkin's Lymphoma (Follicula Lymphoma, Non-Hodgkin | Phase 3 | 2013-11-21 |
| Completed | Pharmacokinetic Study of Thalidomide in Subjects With Multiple Myeloma Multiple Myeloma | Phase 1 | 2013-11-07 |
| Terminated | Observational Registry Study of Chinese Patients Treated With Revlimid (Lenalidomide) Multiple Myeloma | — | 2013-11-01 |
| Completed | Safety Study of Oral Azacitidine (CC-486) as Maintenance Therapy After Allogeneic Hematopoietic Stem Cell Tran Leukemia, Myeloid, Acute, Myelodysplastic Syndromes | Phase 1 / Phase 2 | 2013-10-25 |
| Completed | A Phase 1 QT Study in Healthy Male Subjects Clinical Pharmacology, Healthy Volunteer Study | Phase 1 | 2013-10-18 |
| Completed | Chemotherapy Plus Cetuximab in Combination With VTX-2337 in Patients With Recurrent or Metastatic Squamous Cel Carcinoma, Squamous Cell of Head and Neck | Phase 2 | 2013-10-14 |
| Completed | Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthri Rheumatoid Arthritis | Phase 2 | 2013-10-01 |
| Completed | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabin Breast Tumor, Breast Cancer, Cancer of the Breast | Phase 2 / Phase 3 | 2013-09-26 |
| Completed | Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Deh Hematologic Neoplasms | Phase 1 / Phase 2 | 2013-08-27 |
| Completed | CC-223 and Ketoconazole Drug-Drug Interaction Study Healthy Volunteers | Phase 1 | 2013-07-01 |
| Terminated | Post-authorisation Study of Biological Relapse in Patients With Multiple Myeloma Multiple Myeloma | — | 2013-05-14 |
| Completed | The Efficacy and Safety of Oral Azacitidine Plus Best Supportive Care Versus Placebo and Best Supportive Care Myelodysplastic Syndrome | Phase 3 | 2013-04-26 |
| Completed | Efficacy of Oral Azacitidine Plus Best Supportive Care as Maintenance Therapy in Subjects With Acute Myeloid L Leukemia, Myeloid, Acute | Phase 3 | 2013-04-24 |
| Completed | Study to Evaluate Pharmacokinetics of Pomalidomide in Hepatically Impaired Males Clinical Pharmacology, Healthy Volunteer Study | Phase 1 | 2013-03-01 |
| Completed | Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refrac Multiple Myeloma | Phase 3 | 2013-01-07 |
| Completed | Safety Study of CC-292 and Lenalidomide in Subjects With Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymph Leukemia Lymphocytic Chronic B-Cell | Phase 1 | 2012-12-28 |
| Completed | Efficacy and Safety Study of Ozanimod in Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2012-12-26 |
| Completed | Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Pa Myelodysplastic Syndrome, Leukemia, Myelomonocytic, Chronic | — | 2012-12-17 |
| Completed | A Phase 2 Study of Lenalidomide in Patients With Relapsed or Recurrent Adult T-cell Leukemia-lymphoma Adult T-Cell Leukemia-Lymphoma | Phase 2 | 2012-11-12 |
| Completed | Evaluation of Safety of Pomalidomide in Combination With Dexamethasone (Low Dose) in Patients With Refractory Multiple Myeloma | Phase 3 | 2012-11-06 |
| Completed | 2-part Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of CC-220 & Effect of Food on CC-220 in Hea Healthy | Phase 1 | 2012-11-01 |
| Completed | VTX-2337 and Pegylated Liposomal Doxorubicin (PLD) in Patients With Recurrent or Persistent Epithelial Ovarian Epithelial Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer | Phase 2 | 2012-10-31 |
| Terminated | Study to Determine the Safety and Tolerability of Sotatercept (ACE-011) in Adults With Beta( β)- Thalassemia. Beta Thalassemia Major, Beta Thalassemia Intermedia | Phase 2 | 2012-10-10 |
| Completed | A Phase 2 Study of Lenalidomide to Evaluate the Efficacy in Japanese Patients With Newly Diagnosed Multiple My Multiple Myeloma | Phase 2 | 2012-10-01 |
| Completed | Effect of P-glycoprotein Inhibition on Lenalidomide Pharmacokinetics in Healthy Males Healthy | Phase 1 | 2012-10-01 |
| Completed | A Study to Assess Renal Function Response to Treatment in Patients With Relapsed Multiple Myeloma and Creatini Multiple Myeloma | — | 2012-09-23 |
| Completed | Efficacy and Safety Study of Ozanimod (RPC1063) in Relapsing Multiple Sclerosis Patients Relapsing Multiple Sclerosis | Phase 2 / Phase 3 | 2012-09-18 |
| Completed | Open-label Extended Access Program on Lenalidomide Plus Dexamethasone in Chinese Subjects With Relapsed/Refrac Multiple Myeloma | Phase 2 | 2012-09-11 |
| Completed | A Phase 1 Open-Label Study to Evaluate the Effect of CYP450 and P-gp Inhibition and Induction on the Pharmacok Pharmacology, Clinical, Healthy | Phase 1 | 2012-09-01 |
| Terminated | Study of Pomalidomide (CC-4047) to Evaluate Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Effec Scleroderma, Systemic, Sclerosis, Systemic, Systemic Scleroderma | Phase 2 | 2012-08-09 |
| Completed | Safety and Pharmacokinetics of AVL-292 Following Multiple Doses and the Effect of Food on the Single-dose Phar Healthy | Phase 1 | 2012-08-01 |
| Completed | Study of Azacitidine to Evaluate Safety and Effectiveness for Chinese Patients With Higher Risk Myelodysplasti Myelodysplastic Syndrome (MDS) | Phase 2 | 2012-07-24 |
| Completed | Study of ACY-1215 in Combination With Lenalidomide, and Dexamethasone in Multiple Myeloma Multiple Myeloma | Phase 1 | 2012-07-12 |
| Completed | Study of Pomalidomide to Evaluate the Pharmacokinetics and Safety for Patients With Multiple Myeloma and Impai Multiple Myeloma, Renal Impairment | Phase 1 | 2012-06-01 |
| Completed | A Phase 1 Open-Label Study to Evaluate the Metabolism and Excretion of CC-223 and the Effect of Food on the Ph Safety and Pharmacokinetics in Healthy Volunteer Subjects | Phase 1 | 2012-06-01 |
| Completed | Abraxane in Treatment of Metastatic Breast Cancer Metastatic Breast Cancer | — | 2012-05-31 |
| Completed | Study Assessing Safety, Pharmacokinetics and Efficacy of CC-223 With Either Erlotinib or Oral Azacitidine in A Carcinoma, Non-Small-Cell Lung, Non-Small Cell Lung Cancer | Phase 1 | 2012-05-01 |
| Completed | An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute | — | 2012-05-01 |
| Completed | A Study Being Conducted at Multiple Locations to Compare Safety and Efficacy of Three Different Regimens; (1) Acute Myeloid Leukemia, Acute Myelogenous Leukemia | Phase 2 | 2012-04-27 |
| Completed | Validation of a Comprehensive Health Status Assessment Scale in Elderly Patients (≥ 65 Years) With Hematologic Myelodysplastic Syndromes, Leukemia Myeloid Acute, Multiple Myeloma | — | 2012-04-11 |
| Withdrawn | A Trial of ABI-010 & ABI-007 in Patients With Advanced Non-Hematologic Malignancies Solid Tumor | Phase 1 | 2012-04-01 |
| Completed | Japanese Phase 1 Study to Evaluate Tolerated Dose, Safety, and Efficacy of Pomalidomide in Patients With Refra Multiple Myeloma | Phase 1 | 2012-04-01 |
| Completed | A Phase 1 Study to Evaluate the Pharmacokinetics and Tolerability of Oral Azacitidine in Japanese Patients Wit Myelodysplastic Syndromes | Phase 1 | 2012-04-01 |
| Completed | Study to Determine the Maximum Tolerated Dose for the Combination of Pomalidomide, Bortezomib and Low-Dose Dex Multiple Myeloma | Phase 1 | 2012-02-15 |
| Completed | Study to Evaluate Pharmacokinetics, Food Effect, Safety and Efficacy of Oral Azacitidine Myelodysplastic Syndromes, Leukemia, Myelomonocytic, Chronic, Leukemia, Myeloid, Acute | Phase 1 | 2012-02-07 |
| Completed | Combined Rituximab and Lenalidomide Treatment for Untreated Patients With Follicular Lymphoma Follicular Lymphoma | Phase 3 | 2011-12-29 |
| Completed | A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Lymphoma, T-cell, Peripheral | Phase 1 / Phase 2 | 2011-12-01 |
| Completed | A Phase 1 Study of CC-486 as a Single Agent and in Combination With Carboplatin or ABI-007 in Subjects With Re Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ovarian Neoplasms | Phase 1 | 2011-11-29 |
| Terminated | A Research Study to Assess if CC-930 is Safe in Treating Subjects With Discoid Lupus Erythematosus Discoid Lupus | Phase 2 | 2011-11-01 |
| Completed | Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumor Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier | Phase 1 | 2011-09-12 |
| Completed | A Multiple-ascending-dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Pomalidomide (CC Healthy | Phase 1 | 2011-08-01 |
| Completed | Escalating Dose Study in Subjects With Relapsed or Refractory B Cell Non-Hodgkin Lymphoma, Chronic Lymphocytic B Cell Non-Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, Waldenstrom Macroglobulinemia | Phase 1 | 2011-07-18 |
| Terminated | VTX-2337 in Combination With Radiotherapy in Patients Low-Grade B-cell Lymphomas Low Grade B Cell Lymphoma | Phase 1 / Phase 2 | 2011-07-01 |
| Completed | Study of ACY-1215 Alone and in Combination With Bortezomib and Dexamethasone in Multiple Myeloma Multiple Myeloma | Phase 1 / Phase 2 | 2011-07-01 |
| Completed | A Rollover Study for Patients Who Participated in Other Romidepsin Protocols Lymphoma, Cancer | Phase 2 | 2011-05-01 |
| Completed | An Observational Study to Assess Safety and Outcome of the Various Medication Usage Patterns in Clinical Routi Multiple Myeloma | — | 2011-05-01 |
| Completed | Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologi Glioblastoma Multiforme, Squamous Cell Carcinoma of Head and Neck, Prostate Cancer | Phase 1 | 2011-04-25 |
| Completed | Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer Hematologic Malignancy, Malignant Lymphoma | Phase 1 | 2011-04-01 |
| Completed | Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer Hematologic Malignancy, Malignant Lymphoma | Phase 1 | 2011-04-01 |
| Completed | A Phase 3, Multicenter, Randomized, Open-Label Study to Compare the Efficacy and Safety of Pomalidomide in Com Multiple Myeloma | Phase 3 | 2011-03-11 |
| Completed | A Study to Collect and Evaluate the Safety and Efficacy Information of Korean Multiple Myeloma Patients Treate Multiple Myeloma | — | 2011-03-09 |
| Completed | A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Myelodysplastic Syndromes, Leukemia, Myeloid, Acute | — | 2011-03-03 |
| Terminated | A Phase 1 Trial of ABI-011 in Patients With Advanced Solid Tumors or Lymphomas Advanced Solid Tumors | Phase 1 | 2011-03-01 |
| Completed | Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Multiple Myeloma | Phase 3 | 2011-03-01 |
| Completed | A Safety and Efficacy Study of Revlimid® 5 mg Capsules in Patients With Relapsed or Refractory Multiple Myelom Multiple Myeloma | — | 2011-02-18 |
| Terminated | A Study to Characterize the Safety, PK and Biological Activity of CC-930 in Idiopathic Pulmonary Fibrosis (IPF Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Fibrosis | Phase 2 | 2011-01-01 |
| Completed | A Non-interventional, Observational Post-marketing Registry of Patients Treated With Revlimid (Lenalidomide) i Multiple Myeloma | — | 2011-01-01 |
| Completed | MORE - Monitoring Revlimid - Collecting of Patient Information From Myelodysplastic Syndrome (MDS) Italian Nat Myelodysplastic Syndrome | — | 2011-01-01 |
| Completed | Post Marketing Surveillance to Collect and Evaluate the Safety and Efficacy Information of Korean MDS Patients Myelodysplastic Syndrome | — | 2010-12-27 |
| Completed | Study of Azacitidine in Adult Taiwanese Subjects With Higher-Risk Myelodysplastic Syndromes (MDS) Myelodysplastic Syndromes | Phase 4 | 2010-10-01 |
| Completed | Study of Pomalidomide in Persons With Myeloproliferative-Neoplasm-Associated Myelofibrosis and RBC-Transfusion Primary Myelofibrosis, MPN-associated Myelofibrosis | Phase 3 | 2010-09-08 |
| Completed | Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLB Diffuse Large B-cell Lymphoma | Phase 2 / Phase 3 | 2010-09-02 |
| Completed | Study of Lenalidomide and Low-Dose Dexamethasone in Chinese Subjects With Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2010-08-01 |
| Completed | A Study of Special Use Results Surveillance of Revlimid 5mg Capsules Multiple Myeloma, Myelodysplastic Syndromes | — | 2010-07-20 |
| Completed | Study to Assess Safety, Pharmacokinetics, and Efficacy of Oral CC-223 for Patients With Advanced Solid Tumors, Multiple Myeloma, Diffuse Large B-Cell Lymphoma, Glioblastoma Multiforme | Phase 1 / Phase 2 | 2010-07-20 |
| Completed | A Phase I, Multicenter, Open-label, Dose-escalation Study to Assess the Safety of Lenalidomide in Patients Wit Adult T-cell Leukemia-Lymphoma, Peripheral T-cell Lymphoma | Phase 1 | 2010-07-01 |
| Completed | A Phase 2a Study To Evaluate The Pharmacokinetics, Safety, Efficacy, Tolerability, And Pharmacodynamics of Sot Anemia | Phase 2 | 2010-06-30 |
| Completed | Study of Vidaza Versus Conventional Care Regimens for the Treatment of Acute Myeloid Leukemia (AML) Acute Myeloid Leukemia | Phase 3 | 2010-06-01 |
| Terminated | A Study to Evaluate the Efficacy of Lenalidomide as Maintenance Therapy After Completion of First-line Combina Mantle Cell Lymphoma, Non-Hodgkin's Lymphoma | Phase 3 | 2010-04-01 |
| Completed | Connect™ CLL: The Chronic Lymphocytic Leukemia Disease Registry Chronic Lymphocytic Leukemia | — | 2010-03-19 |
| Completed | Multi-center, Survival Data Collection in Subjects Previously Enrolled in Celgene Protocol CC-5013-MDS-003 Myelodysplastic Syndrome | — | 2010-03-01 |
| Completed | A Study of Lenalidomide Versus Placebo in Subjects With Transfusion Dependent Anemia in Lower Risk Myelodyspla Anemia | Phase 3 | 2010-01-26 |
| Completed | Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Pa Prostate Cancer | Phase 3 | 2009-11-11 |
| Completed | Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocy Relapsed or Refractory Chronic Lymphocytic Leukemia | Phase 2 | 2009-10-19 |
| Completed | Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Pati B-Cell Chronic Lymphocytic Leukemia | Phase 3 | 2009-10-13 |
| Terminated | Connect® MM- The Multiple Myeloma Disease Registry Multiple Myeloma | — | 2009-09-01 |
| Terminated | Study of Lenalidomide in Combination With Sunitinib to Evaluate the Safety and Efficacy in Patients With Renal Renal Cell Carcinoma | Phase 1 / Phase 2 | 2009-09-01 |
| Completed | A Phase I Study to Assess the Safety, Pharmacokinetics, and Potential Effects of Amrubicin on the QT/QTc Inter Advanced Solid Tumors | Phase 1 | 2009-06-01 |
| Completed | A Study to Determine the Efficacy of Lenalidomide Versus Investigator's Choice in Patients With Relapsed or Re Mantle Cell Lymphoma, Lymphoma, Mantle-Cell | Phase 2 | 2009-04-30 |
| Completed | A Safety Confirmation Study on Lenalidomide With Dexamethasone In Japanese Patients With Previously Treated Mu Multiple Myeloma | Phase 3 | 2009-04-28 |
| Completed | A Trial of ABI-007 Versus Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma Malignant Melanoma | Phase 3 | 2009-04-23 |
| Completed | Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenoca Metastatic Pancreatic Cancer | Phase 3 | 2009-03-01 |
| Completed | A Study to Evaluate the Efficacy and Safety of Lenalidomide as Maintenance Therapy for Patients With B-Cell Ch B-cell Chronic Lymphocytic Leukemia | Phase 3 | 2009-01-27 |
| Completed | A Study to Determine the Efficacy and Safety of Lenalidomide in Patients With Mantle Cell NHL Who Have Relapse Mantle Cell Lymphoma | Phase 2 | 2008-12-22 |
| Completed | Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer Advanced Solid Tumors, Lymphoma | Phase 1 | 2008-11-07 |
| Completed | Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function MDS, AML, Solid Tumors | Phase 1 | 2008-11-01 |
| Terminated | Trial of Romidepsin and Bortezomib for Multiple Myeloma Multiple Myeloma | Phase 2 | 2008-09-01 |
| Completed | A Safety, Tolerability and Efficacy Study of ACE-011 in Patients With Osteolytic Lesions of Multiple Myeloma Multiple Myeloma | Phase 2 | 2008-09-01 |
| Completed | Study to Determine Efficacy and Safety of Lenalidomide Plus Low-dose Dexamethasone Versus Melphalan, Prednison Multiple Myeloma | Phase 3 | 2008-08-21 |
| Completed | Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Mul Acute Myeloid Leukemia, Myelodysplastic Syndromes, Lymphoma | Phase 1 | 2008-08-12 |
| Terminated | Efficacy and Safety Study of CC-4047 (Pomalidomide) to Treat Advanced Soft Tissue Sarcoma Soft Tissue Sarcoma | Phase 2 | 2008-08-01 |
| Terminated | A Phase II Study of Single-Agent Lenalidomide in Subjects With Relapsed Or Refractory T-Cell Non-Hodgkin's Lym T-cell Non-Hodgkin's Lymphoma | Phase 2 | 2008-03-01 |
| Completed | NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma Non-Small Cell Lung Cancer, Pancreatic Cancer, Melanoma | Phase 1 | 2008-03-01 |
| Terminated | A Phase I/II Study to Determine the Maximum Tolerated Dose (MTD) and Safety of CC-4047 (Pomalidomide) Administ Carcinoma, Small Cell | Phase 1 / Phase 2 | 2008-02-01 |
| Terminated | First Line Therapy for Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2008-02-01 |
| Completed | ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies Solid Tumors | Phase 1 | 2007-12-01 |
| Completed | Albumin-bound Paclitaxel (ABI-007) for Patients With Advanced Non-Small Cell Lung Cancer Non-Small Cell Lung Carcinoma | Phase 3 | 2007-11-01 |
| Terminated | ABI-008 Trial in Patients With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 1 / Phase 2 | 2007-11-01 |
| Completed | Safety, Pharmacokinetics, and Pharmacodynamics of Oral Azacitidine in Subjects With Myelodysplastic Syndromes, Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myelogenous Leukemia (AML) | Phase 1 | 2007-09-11 |
| Completed | Study of CC-5013 to Evaluate Safety, Pharmacokinetics and Effectiveness for Japanese Patients With Symptomatic Myelodysplastic Syndromes | Phase 2 | 2007-09-01 |
| Completed | AMR PH GL 2007 CL001 Phase 3 Trial in Patients With Small Cell Lung Cancer After Failure of First-Line Chemoth Small Cell Lung Cancer | Phase 3 | 2007-09-01 |
| Completed | Study to Determine the Maximum Tolerated Dose, Safety and Effectiveness of Pomalidomide for Patients With Sick Anemia, Sickle Cell | Phase 1 | 2007-08-01 |
| Completed | Safety Study of Lenalidomide With and Without Dexamethasone in Japanese Subjects With Previously Treated Multi Multiple Myeloma | Phase 1 | 2007-07-01 |
| Completed | Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Malignancies Advanced Cancer | Phase 1 | 2007-07-01 |
| Completed | A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma Peripheral T-cell Lymphoma | Phase 2 | 2007-06-19 |
| Terminated | A Phase I, Open-Label, Dose-Escalation Study of CC-11006 In Subjects With Low- or Intermediate-1 Risk Myelodys Myelodysplastic Syndrome | Phase 1 | 2007-05-01 |
| Completed | A Phase II Study of Pomalidomide in Myelofibrosis With Myeloid Metaplasia Myelofibrosis With Myeloid Metaplasia, Myeloid Metaplasia, Myelofibrosis | Phase 2 | 2007-04-01 |
| Completed | An Extension to Study AZA PH GL 2003 CL 001 Allowing for Continuation of Azacitidine Treatment in Patients Wit Myelodysplastic Syndromes | Phase 3 | 2007-04-01 |
| Completed | ABI-008 Trial in Patients With Hormone-refractory Prostate Cancer Hormone Refractory Prostate Cancer | Phase 1 / Phase 2 | 2007-04-01 |
| Completed | Phase 2 Clinical Trial of NPI-0052 in Patients With Relapsed or Relapsed/Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2007-03-01 |
| Completed | A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic Leukemia Chronic Lymphocytic Leukemia, Leukemia, B-Cell, Chronic | Phase 1 | 2006-12-01 |
| Completed | Study of Amrubicin With or Without Cisplatin Versus Etoposide-cisplatin for Extensive Stage Small Cell Lung Ca Small Cell Lung Cancer | Phase 2 | 2006-11-01 |
| Completed | Study of Amrubicin in Patients With Small Cell Lung Cancer Refractory or Progressive to Prior Therapy Small Cell Lung Cancer | Phase 2 | 2006-11-01 |
| Completed | Gemcitabine Plus Albumin-bound Paclitaxel In Patients With Advanced Metastatic Pancreatic Cancer Metastatic Pancreatic Cancer | Phase 1 / Phase 2 | 2006-11-01 |
| Terminated | ABI-007 With Carboplatin as First-Line Therapy in Patients With Epithelial Ovarian, Primary Peritoneal, or Fal Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms | Phase 1 | 2006-11-01 |
| Completed | AVIDA The Vidaza® (Azacitidine) Patient Registry Myelodysplastic Syndromes | — | 2006-10-31 |
| Completed | Study of Dose-dense Adriamycin Plus Cytoxan (AC) Followed by Either ABI-007 (Abraxane) or Taxol With Bevacizum Breast Cancer | Phase 2 | 2006-08-01 |
| Completed | A Study of Romidepsin (Depsipeptide) in Combination With Gemcitabine in Patients With Pancreatic and Other Adv Pancreatic Cancer | Phase 1 | 2006-07-01 |
| Completed | A Study of Revlimid in the Treatment of Non-Hodgkin's Lymphoma Lymphoma, Non-Hodgkin's | Phase 2 | 2006-06-01 |
| Completed | ABI-007 In Combination With Bevacizumab in Women With Metastatic Breast Cancer Metastatic Breast Cancer | Phase 2 | 2006-06-01 |
| Completed | Phase 1 Clinical Trial of NPI-0052 in Patients With Advanced Solid Tumor Malignancies or Refractory Lymphoma Cancer, Lymphomas | Phase 1 | 2006-05-01 |
| Completed | Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma Multiple Myeloma | Phase 3 | 2006-02-01 |
| Terminated | Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metas Breast Neoplasms, Neoplasm Metastasis | Phase 2 | 2006-02-01 |
| Completed | Phase II Trial Comparing ABI-007 (Abraxane®, Nab®-Paclitaxel) to Taxotere in First Line Therapy of Patients Wi Metastatic Breast Cancer | Phase 2 | 2005-11-01 |
| Terminated | Use of ABI-007 for the Prevention of Vascular Access Graft Failure in Patients Undergoing Hemodialysis Hemodialysis Graft Dysfunction | Phase 2 | 2005-11-01 |
| Completed | Study of the Combination of Lenalidomide and DTIC (Dacarbazine) in Patients With Metastatic Malignant Melanoma Malignant Melanoma | Phase 1 | 2005-09-01 |
| Terminated | A Phase I/II Study of ABI-007 (Abraxane®, Nab®-Paclitaxel)and Vinorelbine in Patients With Stage IV (Metastati Stage IV (Metastatic) Breast Cancer | Phase 1 / Phase 2 | 2005-08-01 |
| Completed | Lenalidomide (Revlimid®, CC-5013) in Subjects With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Non-Hodgkins Lymphoma | Phase 2 | 2005-06-01 |
| Completed | An Open Label Study in Patients With Advanced NSCLC With ABI-007(Abraxane) in Combination With Carboplatin Non-Small Cell Lung Cancer (NSCLC) | Phase 2 | 2005-03-01 |
| Completed | A Single Agent Phase II Study of Romidepsin (Depsipeptide, FK228) in the Treatment of Cutaneous T-cell Lymphom Cutaneous T-cell Lymphoma | Phase 2 | 2005-01-01 |
| Completed | Alternative Dosing Regimens of Subcutaneous Azacitidine for Myelodysplastic Syndromes Myelodysplastic Syndromes | Phase 2 | 2005-01-01 |
| Completed | Study of Albumin-bound Paclitaxel (Abraxane) in Combination With Carboplatin and Herceptin in Patients With Ad Breast Cancer | Phase 2 | 2004-06-01 |
| Completed | Continuation Trial Evaluating the Tolerability and Activity of FK228 in Patients That Completed Prior Study Wi Carcinoma, Renal Cell, Prostatic Neoplasms | Phase 2 | 2004-04-01 |
| Completed | A Survival Study in Patients With High Risk Myelodysplastic Syndromes Comparing Azacitidine Versus Conventiona Myelodysplastic Syndromes | Phase 3 | 2003-11-01 |
| Completed | Safety and Efficacy of Single-agent CC-5013 in Subjects With Relapsed and Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2003-07-01 |
| Completed | Trial of ABI-007 in Previously Treated Patients With Metastatic Melanoma Melanoma, Metastases | Phase 2 | 2003-07-01 |
| Completed | Lenalidomide Safety/Efficacy in Myelodysplastic Syndromes (MDS) Associated With a Deletion (Del)(5q) Cytogenet Myelodysplastic Syndromes | Phase 2 | 2003-06-01 |
| Completed | A Research Study for Patients With Prostate Cancer Prostate Cancer, Metastases | Phase 2 | 2003-05-07 |
| Completed | A Research Study for Patients With Metastatic Renal Cell Carcinoma Carcinoma, Renal Cell, Neoplasm Metastasis | Phase 2 | 2003-05-01 |
| Completed | A Companion Study for Studies THAL-MM-003, CC-5013-MM-009, and CC-5013-MM-010 for Subjects With Multiple Myelo Multiple Myeloma | Phase 3 | 2003-04-01 |
| Completed | A Study of CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Multiple Myeloma | Phase 3 | 2003-01-01 |
| Completed | CC-5013 Plus Dexamethasone Versus Dexamethasone Alone in Previously Treated Subjects With Multiple Myeloma Multiple Myeloma | Phase 3 | 2003-01-01 |
| Completed | Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma Melanoma, Neoplasm Metastasis | Phase 3 | 2002-10-01 |
| Completed | Phase 1 Study OF CDC-501 in Patients With Solid Tumors Neoplasms | Phase 1 | 2002-06-01 |
| Completed | CDC-501 Therapy in Relapsed or Refractory Multiple Myeloma Multiple Myeloma | Phase 2 | 2002-04-01 |
| Completed | Study of the Safety and Efficacy of CC-5013 Treatment For Patients With Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 2 | 2002-02-01 |
| Completed | Thalidomide 100 mg/Day Versus Thalidomide 400 mg/Day in Relapse Refractory Multiple Myeloma Multiple Myeloma | Phase 2 / Phase 3 | 2001-12-01 |
| Completed | Study to Determine the Safety and Preliminary Efficacy of CC-1088 in the Treatment of Myelodysplastic Syndrome Myelodysplastic Syndrome | Phase 2 | 2001-10-01 |
| Completed | A Safety Study of ABI-007 for In-Stent Restenosis Angina Pectoris, Coronary Artery Disease | Phase 2 | 2001-09-01 |
| No Longer Available | Expanded Access for Marizomib Solid Tumor | — | — |
| Available | Individual Patient Compassionate Use of Fedratinib Myelofibrosis | — | — |
| No Longer Available | Expanded Access for CC-4047 Multiple Myeloma | — | — |
| Approved For Marketing | Pomalidomide (POM) in Combination With Low Dose Dexamethasone (LD-Dex) in Patients With Relapsed or Refractory Multiple Myeloma | — | — |
| No Longer Available | Expanded Access for ACE-011 Myelodysplastic Syndrome | — | — |
| No Longer Available | Expanded Access for AG-221 Acute Myeloid Leukemia | — | — |
| No Longer Available | Expanded Access for CC-2001 Dermatologic, Other | — | — |
| Available | Expanded Access Protocol (EAP) for Participants Receiving Idecabtagene Vicleucel That is Nonconforming for Com Multiple Myeloma | — | — |
| Approved For Marketing | Expanded Access for CC-486 Acute Myelogenous Leukemia (AML) | — | — |